Senators still spoiling for fight over Crawford
This article was originally published in Clinica
Lester Crawford has moved one step closer to becoming the next FDA commissioner. The Senate Health, Education, Labor and Pensions committee approved his nomination by a voice vote yesterday. However two Democratic Senators have placed a hold on further action barring his name from coming up for a vote in the full Senate.
You may also be interested in...
The addition of the question “Was this device serviced by a third party servicer?” to adverse event reports filed through the US FDA’s electronic Medical Device Reporting system could prove helpful for the agency and device makers, experts tell Medtech Insight. Industry has long complained about poor work performed by servicers – and loudly groused that they’re not regulated.
Attorneys tell Medtech Insight a recent proposal to review regulations every 10 years could lift some burdens from the medical device industry, but warned that the full effects may not be seen for some time.
A nasal spray formulated using compounds already approved by regulatory bodies in Europe and the US can “prevent and slow” transmission of COVID-19, according to UK researchers who are now seeking a partner to commercialize the product.